Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.

Bergh AC, Evaldsson C, Pedersen LB, Geisler C, Stamatopoulos K, Rosenquist R, Rosén A.

Haematologica. 2014 Nov;99(11):1722-30. doi: 10.3324/haematol.2014.106054. Epub 2014 Aug 1.

PMID:
25085355
[PubMed - in process]
Free PMC Article
2.

Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.

Cesano A, Perbellini O, Evensen E, Chu CC, Cioffi F, Ptacek J, Damle RN, Chignola R, Cordeiro J, Yan XJ, Hawtin RE, Nichele I, Ware JR, Cavallini C, Lovato O, Zanotti R, Rai KR, Chiorazzi N, Pizzolo G, Scupoli MT.

Haematologica. 2013 Apr;98(4):626-34. doi: 10.3324/haematol.2012.071910. Epub 2012 Nov 9.

PMID:
23144194
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, Lamnissou K, Caligaris-Cappio F, Stamatopoulos K, Ghia P, Muzio M, Belessi C.

Haematologica. 2011 Nov;96(11):1644-52. doi: 10.3324/haematol.2011.044792. Epub 2011 Jul 12.

PMID:
21750087
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.

Del Giudice I, Chiaretti S, Santangelo S, Tavolaro S, Peragine N, Marinelli M, Ilari C, Raponi S, Messina M, Nanni M, Mauro FR, Piciocchi A, Bontempi K, Rossi D, Gaidano G, Guarini A, Foà R.

Am J Hematol. 2014 Jan;89(1):74-82.

PMID:
24030933
[PubMed - indexed for MEDLINE]
5.

Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.

Colombo M, Cutrona G, Reverberi D, Fabris S, Neri A, Fabbi M, Quintana G, Quarta G, Ghiotto F, Fais F, Ferrarini M.

Mol Med. 2011;17(7-8):834-9. doi: 10.2119/molmed.2011.00047. Epub 2011 Apr 28.

PMID:
21541442
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.

Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, Vigna E, Gentile M, Zupo S, Chiorazzi N, Morabito F, Ferrarini M.

Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.

PMID:
18287138
[PubMed - indexed for MEDLINE]
Free Article
7.

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

Petlickovski A, Laurenti L, Li X, Marietti S, Chiusolo P, Sica S, Leone G, Efremov DG.

Blood. 2005 Jun 15;105(12):4820-7. Epub 2005 Feb 22.

PMID:
15728130
[PubMed - indexed for MEDLINE]
Free Article
8.

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G.

Blood. 2003 Feb 1;101(3):1087-93. Epub 2002 Sep 26.

PMID:
12393552
[PubMed - indexed for MEDLINE]
Free Article
9.

Oxidized low density lipoprotein enhanced RANKL expression in human osteoblast-like cells. Involvement of ERK, NFkappaB and NFAT.

Mazière C, Salle V, Gomila C, Mazière JC.

Biochim Biophys Acta. 2013 Oct;1832(10):1756-64. doi: 10.1016/j.bbadis.2013.05.033. Epub 2013 Jun 10.

PMID:
23756197
[PubMed - indexed for MEDLINE]
Free Article
10.

A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.

Hoogeboom R, van Kessel KP, Hochstenbach F, Wormhoudt TA, Reinten RJ, Wagner K, Kater AP, Guikema JE, Bende RJ, van Noesel CJ.

J Exp Med. 2013 Jan 14;210(1):59-70. doi: 10.1084/jem.20121801. Epub 2013 Jan 7.

PMID:
23296468
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Chen SS, Batliwalla F, Holodick NE, Yan XJ, Yancopoulos S, Croce CM, Rothstein TL, Chiorazzi N.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1500-7. doi: 10.1073/pnas.1300616110. Epub 2013 Apr 2.

PMID:
23550156
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.

Marincevic M, Cahill N, Gunnarsson R, Isaksson A, Mansouri M, Göransson H, Rasmussen M, Jansson M, Ryan F, Karlsson K, Adami HO, Davi F, Jurlander J, Juliusson G, Stamatopoulos K, Rosenquist R.

Haematologica. 2010 Sep;95(9):1519-25. doi: 10.3324/haematol.2009.021014. Epub 2010 Apr 26.

PMID:
20421269
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.

Packham G, Krysov S, Allen A, Savelyeva N, Steele AJ, Forconi F, Stevenson FK.

Haematologica. 2014 Jul;99(7):1138-48. doi: 10.3324/haematol.2013.098384.

PMID:
24986876
[PubMed - in process]
Free PMC Article
14.

Endogenous antigen tunes the responsiveness of naive B cells but not T cells.

Zikherman J, Parameswaran R, Weiss A.

Nature. 2012 Sep 6;489(7414):160-4. doi: 10.1038/nature11311.

PMID:
22902503
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Chu CC, Catera R, Zhang L, Didier S, Agagnina BM, Damle RN, Kaufman MS, Kolitz JE, Allen SL, Rai KR, Chiorazzi N.

Blood. 2010 May 13;115(19):3907-15. doi: 10.1182/blood-2009-09-244251. Epub 2010 Jan 28.

PMID:
20110421
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.

Rosén A, Murray F, Evaldsson C, Rosenquist R.

Semin Cancer Biol. 2010 Dec;20(6):400-9. doi: 10.1016/j.semcancer.2010.09.004. Epub 2010 Sep 21. Review.

PMID:
20863893
[PubMed - indexed for MEDLINE]
18.

Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.

Mongini PK, Blessinger C, Posnett DN, Rudich SM.

J Immunol. 1989 Sep 1;143(5):1565-74.

PMID:
2788188
[PubMed - indexed for MEDLINE]
19.

Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

García-Muñoz R, Llorente L.

Immunology. 2014 Aug;142(4):536-50. doi: 10.1111/imm.12285. Review.

PMID:
24645778
[PubMed - indexed for MEDLINE]
20.

B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.

Allsup DJ, Kamiguti AS, Lin K, Sherrington PD, Matrai Z, Slupsky JR, Cawley JC, Zuzel M.

Cancer Res. 2005 Aug 15;65(16):7328-37.

PMID:
16103084
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk